GMP– tag –
-
iPS Cells & Regenerative Medicine
Europe’s Biotech Vanguard: Ori Biotech’s Modular Automation Reshapes Cell and Gene Therapy Manufacturing
PharmTech ヨーロッパ Overview European biotechnology firms are pioneering advanced manufacturing solutions to overcome critical production hurdles in cell and gene therapies. Ori Biotech, in strategic collaborations with Cell Therapies, ... -
New Technology
iPSC-Derived Cell Therapy Pipeline 2026: From Disease Modeling to Expanding Clinical Applications
BioInformant USA Overview As of 2026, the iPSC-derived cell therapy pipeline shows rapid advancements in disease modeling and drug discovery, though broad clinical use in human patients still faces challenges. iPSC-derived cells hold imm... -
New Technology
Laser-Precision 3D Bioprinting: Ushering in a New Era for Organoid and Tissue Engineering
技術情報発信(素材技術を未来へ) Japan Overview Advances in 3D bioprinting are enabling the creation of highly complex organoid and tissue models, transcending the limitations of random self-assembly. Key innovations, such as Poietis' NG...